1. AMG900 as novel inhibitor of the translationally controlled tumor protein. (25th January 2021) Authors: Fischer, Nicolas; Seo, Ean-Jeong; Klinger, Anette; Fleischer, Edmond; Efferth, Thomas Journal: Chemico-biological interactions Issue: Volume 334(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion. (25th September 2022) Authors: Lu, Xiaohua; Elbadawi, Mohamed; Blatt, Sebastian; Saeed, Mohamed E.M.; Xiao, Xiaolin; Ma, Xiao; Fleischer, Edmond; Kämmerer, Peer W.; Efferth, Thomas Journal: Chemico-biological interactions Issue: Volume 365(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344. (October 2020) Authors: Dawood, Mona; Fleischer, Edmond; Klinger, Anette; Bringmann, Gerhard; Shan, Letian; Efferth, Thomas Journal: Pharmacological research Issue: Volume 160(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Naphthoquinone derivatives as P-glycoprotein inducers in inflammatory bowel disease: 2D monolayers, 3D spheroids, and in vivo models. (May 2022) Authors: Mahmoud, Nuha; Hegazy, Mohamed-Elamir F.; Wadie, Walaa; Elbadawi, Mohamed; Fleischer, Edmond; Klinger, Anette; Bringmann, Gerhard; Khayyal, Mohamed T.; Efferth, Thomas Journal: Pharmacological research Issue: Volume 179(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗